Login / Signup

The role of erythropoietin to prevent red blood cell transfusion in a 2018-2020 two-center cohort of preterm infants.

Noémie BaillyRoselyne BratGeraldine Favrais
Published in: Blood transfusion = Trasfusione del sangue (2024)
No benefit of rHu-EPO in preventing pRBCT was observed in our cohort. The place of rHu-EPO in future requires careful consideration of the population concerned, adjustment of the therapeutic schedule and evolution of the indications for pRBCT.
Keyphrases
  • red blood cell
  • preterm infants
  • low birth weight
  • cardiac surgery
  • sickle cell disease
  • acute kidney injury
  • recombinant human
  • preterm birth